Invention Application
- Patent Title: NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF
-
Application No.: US17551723Application Date: 2021-12-15
-
Publication No.: US20220107310A1Publication Date: 2022-04-07
- Inventor: Michael GERG , Dieter HEINDL , Lars HILLRINGHAUS , Klaus HIRZEL , Caroline Dorothea HOJER , Florian HUBER , Hans-Peter JOSEL , Thomas MEIER , Michael SCHRAEML , Edgar VOSS
- Applicant: Roche Diagnostics Operations, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Main IPC: G01N33/543
- IPC: G01N33/543 ; C07K16/44

Abstract:
The present invention relates to a monoclonal antibody capable of binding to biotin. In one embodiment the monoclonal antibody according to the invention also does not bind to a biotin moiety on a biotinylated molecule, wherein the biotin moiety is attached to the molecule via the carbon atom of the carboxyl function of the valeric acid moiety of biotin. Also disclosed is a method for generation of an antibody as disclosed herein. The monoclonal antibody according to the invention is of specific use in a method for measuring an analyte in a sample, wherein a (strept)avidin/biotin pair is used to bind a biotinylated analyte specific binding agent to a (strept)avidin coated solid phase.
Public/Granted literature
- US12025613B2 Biotin-specific monoclonal antibody and use thereof Public/Granted day:2024-07-02
Information query
IPC分类: